يعرض 1 - 10 نتائج من 36 نتيجة بحث عن '"Neoplasia intraepitelial prostática"', وقت الاستعلام: 0.83s تنقيح النتائج
  1. 1
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: Epstein J. The prostate and seminal vesicles. En: Mills S, Carter D, Reuter V, Greenson J, Stoler M, editors. Sternber's diagnostic surgical pathology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 2083-2132.; Young R, Srigley J, Amin M, Ulbright T, Cubilla A, editors. Atlas of tumor pathology. Tumor of the prostate gland, seminal vesicles, male uretra and penis. Washington, DC: Armed Forces Institute of Pathology; 1998.; Rohr LR. Incidental adenocarcinoma in transurethral resections of the prostate. Partial versus complete microscopic examination. Am J Surg Pathol. 1987 Jan; 11(1):53-8.; McDowell PR, Fox WM, Epstein JI. Is submission of remaining tissue necessary when incidental carcinoma of the prostate is found on transurethral resection?. Hum Pathol. 1994 May; 25 (5): 493-7.; Coley CM, Barry MJ, Fleming C, Fahs MC, Mulley AG. Early detection of prostate cancel-. Part I: Prior probability and effectiveness of test. American College of Physicians. Ann Intern Med. 1997 Mar 15; 126(6):394-406.; Eble JN, Sauter Epstein J, Sesterhenn I, editors. World Health Organization Classification of tumors. Pathology and genetics of tumor of the urinary system and male genital organs. Lyon, Francia : IARC Press; 2005.; Lester CS, editor. Manual of surgical pathology. Philadelphia: Lippincott Williams & Wilkins; 2001.; Hruban R, Westra W, Phelps T, Isacson C, editors. Surgical pathology dissection. An illustrated guide. New York: Springer; 2003.; Murphy WM, Dean PJ, Brasfield JA, Tatum L. Incidental carcinoma of the prostate: how much sampling is adequate?. Am J Surg Pathol. 1986; 10:170-4.; Newman AJ, Graham MA, Carlton CE, Lieman S. Incidental carcinoma of the prostate at the time transurethral resection: importance of evaluating every chip. J Urol. 1982 Nov; 128(5):948-50.; Humphrey P., Walther P., Adenocarcinoma of the prostate. I. Tissue sampling considerations. Am J Clin Pathol. 1993. Jun; 99(6): 746-59.; Rosai J, editor. Rosai and Ackerman's surgical pathology. 9th ed. London: Mosby; 2004.; https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/532/573Test; Núm. 2 , Año 2009 : Abril - Junio; 75; 70; 18; Revista Repertorio de Medicina y Cirugía; https://repositorio.fucsalud.edu.co/handle/001/2427Test; https://doi.org/10.31260/RepertMedCir.v18.n2.2009.532Test

  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية

    المصدر: Acta Biológica Colombiana; Vol. 21 Núm. 3 (2016); 533-542 ; Acta Biológica Colombiana; Vol. 21 No. 3 (2016); 533-542 ; 1900-1649 ; 0120-548X

    وصف الملف: application/pdf; text/html

    العلاقة: https://revistas.unal.edu.co/index.php/actabiol/article/view/50477/pdf_art8_21%283%29Test; https://revistas.unal.edu.co/index.php/actabiol/article/view/50477/57611Test; Al-Shanti N, Saini A, Stewart CE. Two-Step versus One-Step RNA-to-CT 2-Step and One-Step RNA-to-CT 1-Step: validity, sensitivity, and efficiency. J Biomol Tech. 2009;20(3):172–179.; Alumkal JJ y Herman JG. Distinct epigenetic mechanisms distinguish TMPRSS2-ERG fusion-positive and -negative prostate cancers. Cancer Discov. 2012;2(11):979-981. Doi:10.1158/2159-8290.CD-12-0392; Arora R, Koch MO, Eble J N, Ulbright TM, Li L, Cheng L. Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate. Cancer. 2004;100(11):2362-2366. Doi:10.1016/j.ccr.2010.05.026 Applied Biosystems. Creating Standard Curves with Genomic DNA or Plasmid DNA Templates for Use in Quantitative PCR (2003). [Cited 6 may 2015]. Available at: http://www6.appliedbiosystems.com/support/tutorials/pdf/quant_pcr.pdfTest; Ateeq B, Tomlins SA, Laxman B, Asangani IA, Cao Q, Cao X, et al. Therapeutic targeting of SPINK1-positive prostate cancer. Sci Transl Med. 2011;3(72):72ra17. Doi:10.1126/scitranslmed.3001498; Attard G, Clark J, Ambroisine L, Mills IG, Fisher G, Flohr P, et al. Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer. Br J Cancer. 2008;99(2):314-320. Doi:10.1038/sj.bjc.6604472; Barbieri CE, Baca SC, Lawrence MS, Demichelis F, Blattner M, Theurillat JP, et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet. 2012;44(6):685-689. Doi:10.1038/ng.2279; Barry M, Perner S, Demichelis F, Rubin MA. TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications. Urology. 2007;70(4):630-633. Doi:10.1016/j.urology.2007.08.032; Bastacky SI, Wojno KJ, Walsh PC, Carmichael MJ, Epstein JI. Pathological features of hereditary prostate cancer. J Urol. 1995;153(3 Pt 2):987-992.; Bowen C, Bubendorf L, Voeller HJ, Slack R, Willi N, Sauter G, et al. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. Cancer Res. 2000;60(21):6111-6115.; Börno ST, Fischer A, Kerick M, Fälth M, Laible M, Brase JC, et al. Genome-wide DNA methylation events in TMPRSS2-ERG fusion-negative prostate cancers implicate an EZH2-dependent mechanism with miR-26a hypermethylation. Cancer Discov. 2012;2(11):1024-1035. Doi:10.1158/2159-8290.CD-12-0041; Clark J, Merson S, Jhavar S, Flohr P, Edwards S, Foster CS, et al. Diversity of TMPRSS2-ERG fusion transcripts in the human prostate. Oncogene 2007;26(18):2667-73. Doi:10.1038/sj.onc.1210070; Epstein JI, Allsbrook WC, Amin MB, Egevad LL, Committee IG. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol. 2005;29(9):1228-1242.; Fernández-Serra A, Rubio L, Calatrava A, Rubio-Briones J, Salgado R, Gil-Benso R. et. al. Molecular characterization and clinical impact of TMPRSS2-ERG rearrangement on prostate cancer: comparison between FISH and RT-PCR. Biomed Res Int. 2013;2013:465179. Doi:10.1155/2013/465179; Flavin RJ, Pettersson A, Hendrickson WK, Fiorentino M, Finn SP, Kunz L, et al. SPINK1 Protein Expression and Prostate Cancer Progression. Clin Cancer Res. 2014;20(18):4904-4911. Doi:10.1158/1078-0432.CCR-13-1341; Grupp K, Diebel F, Sirma H, Simon R, Breitmeyer K, Steurer S, et al. SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence. Prostate. 2013;73(15):1690-1698. Doi:10.1002/pros.22707; Guo Cc, Zuo G, Cao D, Troncoso P, Czerniak BA. Prostate cancer of transition zone origin lacks TMPRSS2-ERG gene fusion. Mod Pathol. 2009;22(7):866-871. Doi:10.1038/modpathol.2009.57; Gurel B, Ali TZ, Montgomery EA, Begum S, Hicks J, Goggins M, et al. NKX3.1 as a marker of prostatic origin in metastatic tumors: Am J Surg Pathol. 2010;34(8):1097-1105. Doi:10.1097/PAS.0b013e3181e6cbf3; Han B, Mehra R, Dhanasekaran SM, Yu J, Menon A, Lonigro RJ, Wang X, Gong Y, et al. A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer. Cancer Res. 2008;68(18): 7629-7637. Doi:10.1158/0008-5472.CAN-08-2014; IARC. International Agency for Research in Cancer. Globocan 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. [Cited 6 may 2015]. Available at: http://globocan.iarc.fr/Pages/online.aspxTest.; Jhavar S, Brewer D, Edwards S, Kote-Jarai Z, Attard G, Clark J, et al. Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer. BJU Int. 2009;103(9):1256-1269. Doi:10.1111/j.1464-410X.2008.08200.x; Kunderfranco P, Mello-Grand M, Cangemi R, Pellini S, Mensah A, Albertini V, et al. ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer: PLoS One. 2010;5(5):e10547. Doi:10.1371/journal.pone.0010547; Lapointe J, Li C, Giacomini CP, Salari K, Huang S, Wang P, et al. Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis. Cancer Res. 2007;67(18): 8504-8510. Doi:10.1158/0008-5472.CAN-07-0673.; Leinonen KA, Saramäki OR, Furusato B. Loss of PTEN Is Associated with Aggressive Behavior in ERG-Positive Prostate Cancer, Cancer Epidemiol Biomarkers Prev. 2013;22(12):2333-44. Doi:10.1158/1055-9965; Leinonen KA, Tolonen TT, Bracken H, Stenman UH, Tammela TL, Saramäki OR, et al. Association of SPINK1 expression and TMPRSS2: ERG fusion with prognosis in endocrine-treated prostate cancer: Clin Cancer Res. 2010;6(10):2845-2851. Doi:10.1158/1078-0432.CCR-09-2505; Lippolis G, Edsjö A, Stenman UH, Bjartell A. A high-density tissue microarray from patients with clinically localized prostate cancer reveals ERG and TATI exclusivity in tumor cells. Prostate Cancer Prostatic Dis. 2013;16(2):145-150. Doi:10.1038/pcan.2013.7; Mehra R, Tomlins SA, Shen R, Nadeem O, Wang L, Wei JT, et al. Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer. Mod Pathol. 2007;20(5):538-544. Doi:10.1038/modpathol.3800769; Mertz KD, Setlur SR, Dhanasekaran SM, Demichelis F, Perner S, Tomlins SA, et al. Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model. Neoplasia. 2007;9(3):200-206.; Mohamed N, Elfaitouri A, Fohlman J, Friman G, Blomberg J. A sensitive and quantitative single-tube real-time reverse transcriptase-PCR for detection of enteroviral RNA. J Clin Virol. 2004;30(2):150-156. Doi:10.1016/j.jcv.2003.08.016; Mori R, Wang Q, Danenberg KD, Pinski JK, Danenberg PV. Both beta-actin and GAPDH are useful reference genes for normalization of quantitative RT-PCR in human FFPE tissue samples of prostate cancer. Prostate. 2008;68(14):1555-60. Doi:10.1002/pros.20815; Paju A, Hotakainen K, Cao Y, Laurila T, Gadaleanu V, Hemminki A, et al. Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells. Eur Urol. 2007;52(6):1670-1679. Doi:10.1016/j.eururo.2007.01.096; Park K, Tomlins SA, Mudaliar KM, Chiu YL, Esgueva R, Mehra R, et al. Antibody-based detection of ERG rearrangement-positive prostate cancer. Neoplasia. 2010;12(7):590-598.; Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29(9):e45.; Pflueger D, Rickman DS, Sboner A, Perner S, Lafargue CJ, Svensson MA, et al. N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer. Neoplasia. 2009;11(8):804-811.; Rose A, Xu Y, Chen Z, Fan Z, Stamey TA, McNeal JE, et al. Comparative gene and protein expression in primary cultures of epithelial cells from benign prostatic hyperplasia and prostate cancer. Cancer Lett. 2005;227(2):213-22. Doi:10.1016/j.canlet.2005.01.037; Shin YJ Y Kim JH. The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells. PLoS One. 2012;7(1):e30393. Doi:10.1371/journal.pone.0030393; Thangapazham R, Saenz F, Katta S, Mohamed AA, Tan SH, Petrovics G, et al. Loss of the NKX3.1 tumor suppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer. BMC Cancer. 2014;14:16. Doi:10.1186/1471-2407-14-16.; Tomlins SA, Bjartell A, Chinnaiyan AM, Jenster G, Nam RK, Rubin MA, et al. ETS gene fusions in prostate cancer: from discovery to daily clinical practice. Eur Urol. 2009;56(2):275-286. Doi:10.1016/j.eururo.2009.04.036; Tomlins SA, Laxman B, Dhanasekaran SM, Helgeson BE, Cao X, Morris DS, et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature. 2007;448(7153):595-599. Doi:10.1038/nature06024; Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun X-W, et al. Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer. Science. 2005;310(5748): 644-648. Doi:10.1126/science.1117679; Tomlins SA, Rhodes DR, Yu J, Varambally S, Mehra R, Perner S, et al. The role of SPINK1 in ETS rearrangement-negative prostate cancers. Cancer Cell. 2008;13(6):519-528. Doi:10.1016/j.ccr.2008.04.016; Tu JJ, Rohan S, Kao J, Kitabayashi N, Mathew S, Chen YT. Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues. Mod Pathol. 2007;20(9):921-8. Doi:10.1038/modpathol.3800903; URI Genomics & Sequencing Center. Calculator for determining the number of copies of a template (29 de ene 2004). [Cited 6 may 2015]. Available at: http://cels.uri.edu/gsc/cndna.htmlTest; Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3(7):RESEARCH0034.; Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature. 2002;419(6907):624-629. Doi:10.1038/nature01075; Wacker MJ y Godard MP. Analysis of one-step and two-step real-time RT-PCR using SuperScript III. J Biomol Tech. 2005;16(3):266-271.; Wang J, Cai Y, Ren C, Ittmann M. Expression of Variant TMPRSS2/ERG Fusion Messenger RNAs Is Associated with Aggressive Prostate Cancer. Cancer Res. 2006;66(17):8347-8351. Doi:10.1158/0008-5472.CAN-06-1966; Wen G, Yang J, Luo Q, Hu Z, Song N, Zhang R, et al. A one-step real-time reverse transcription-polymerase chain reaction detection of classical swine fever virus using a minor groove binding probe. Vet Res Commun. 2010;34(4):359-369. Doi:10.1007/s11259-010-9363-8; Yoshimoto M, Joshua AM, Chilton-Macneill S, Bayani J, Selvarajah S, Evans AJ, et al. Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement. Neoplasia 2006;8(6):465-469. Doi:10.1593/neo.06283; https://revistas.unal.edu.co/index.php/actabiol/article/view/50477Test

  6. 6
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: https://revistas.unal.edu.co/index.php/actabiol/article/view/50477Test; Universidad Nacional de Colombia Revistas electrónicas UN Acta Biológica Colombiana; Acta Biológica Colombiana; Segura Moreno, Yenifer Yamile and Serrano López, Martha Lucía (2016) Estandarización del protocolo para la detección de las fusiones TMPRSS2:ERG y de la expresión de los genes EZH2, SPINK-1 y NKX3.1 en cáncer de próstata (CaP). Acta Biológica Colombiana, 21 (3). pp. 533-542. ISSN 1900-1649; https://repositorio.unal.edu.co/handle/unal/61166Test; http://bdigital.unal.edu.co/59974Test/

  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية